JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (8): 1-6.doi: 10.6040/j.issn.1671-7554.0.2016.378

    Next Articles

CYLD improves bladder cancer gemcitabine chemosensitivity via suppressing autophagy

YIN Lei1, YIN Rui2, LI Wenjia3, LIU Shuai1, L(¨overU)Jiaju1   

  1. 1. Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    2. Center for Reproductive Medicine Affiliated to Shandong University, Jinan 250001, Shandong, China;
    3. Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2016-04-06 Online:2017-08-10 Published:2017-08-10

PDF (PC)

183

Abstract: Objective To explore the tumor suppressor CYLD in improving bladder cancer gemcitabine chemosensitivity. Methods The CYLD over-expressing plasmid was constructed and transfected into human bladder cancer cell lines T24 and 253J, then the cells were divided into control group treated with liposome, empty plasmid transfection group and CYLD group. The effect of CYLD on the migration/invasion ability of bladder cancer cells was measured by Transwell assays. The chemosensitivity to gemcitabine was tested by CCK-8 assay. Autophagy-related proteins were detected by Western blotting, acridine orange staining, and transmission electron microscopy. Results Compared with the control group and empty plasmid transfection group, CYLD group had significantly decreased cell numbers in Transwell chambers(P<0.05); significantly reduced 50% cell growth inhibition in 24 h(IC50)(P<0.05); decreased expressions of LC3 and Beclin 1, but elevated expression of p62; decreased autophagy lysosomes and autophagic vacuoles. Conclusion CYLD can decrease the ability of migration/invasion and improve gemcitabine chemosensitivity by sup- 山 东 大 学 学 报 (医 学 版)55卷8期 -殷雷,等.CYLD抑制自噬提高膀胱癌细胞吉西他滨化疗敏感性 \=-pressing autophagy in bladder cancer cells.

Key words: CYLD gene, Chemosensitivity, Autophagy, Bladder cancer, Gemcitabine

CLC Number: 

  • R574
[1] Zhang Y, Sun Y, Chen T, et al. Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population[J]. Int J Mol Sci, 2014, 15(11):19330-19341.
[2] Sun L, Lu J, Niu Z, et al. A Potent chemotherapeutic strategy with Eg5 inhibitor against gemcitabine resistant bladder cancer[J]. PLoS One, 2015, 10(12):e14484-14499.
[3] Ni F, Zhao H, Cui H, et al. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma[J]. Cancer Lett, 2015, 356(2 Pt B):809-818.
[4] Liu S, Lv J, Han L, et al. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis(CYLD)in vascular smooth muscle cells[J]. Biochem Biophys Res Commun, 2012, 420(1):78-83.
[5] Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy(3rd edition)[J]. Autophagy, 2016, 12(1):1-222.
[6] Desantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014[J]. CA Cancer J Clin, 2014, 64(4):252-271.
[7] Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer:long-term results in 1,054 patients[J]. J Clin Oncol, 2001, 19(3):666-675.
[8] Bignell GR, Warren W, Seal S, et al. Identification of the familial cylindromatosis tumour-suppressor gene[J]. Nat Genet, 2000, 25(2):160-165.
[9] Sun B, Li L, Ma W, et al. MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD[J]. Tumour Biol, 2016, 37(6):7981-7987.
[10] Yang JM, Xu Z, Wu H, et al. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells[J]. Mol Cancer Res, 2003, 1(6):420-427.
[11] Hunstig F, Schulz S, Nieten I, et al. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma[J]. J Cancer Res Clin Oncol, 2016, 142(4):845-848.
[12] Zhao Y, Ma CA, Wu L, et al. CYLD and the NEMO zinc finger regulate tumor necrosis factor signaling and early embryogenesis[J]. J Biol Chem, 2015, 290(36):22076-22084.
[13] 向波, 易梅, 李小玲, 等. 细胞自噬在肿瘤发生发展中的作用[J]. 生物化学与生物物理进展, 2012, 3:241-249. XIANG Bo, YI Mei, LI Xiaoling, et al. Progress on role of autophagy in cancer[J]. Progress in Biochemistry and Biophysics, 2012, 3:241-249.
[14] Ozpolat B, Benbrook DM. Targeting autophagy in cancer management-strategies and developments[J]. Cancer Manag Res, 2015, 7:291-299.
[15] Bauckman KA, Mysorekar IU. Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells[J]. Autophagy, 2016, 12(5):850-863.
[16] Chen L, Ye HL, Zhang G, et al. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells[J]. PLoS One, 2014, 9(1):e85771-85783.
[17] Liu S, Xie F, Wang H, et al. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma:the effect is autophagy-associated[J]. Oncol Rep, 2015, 33(3):1372-1380.
[1] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1-6.
[2] ZHAO Shanshan, LI Xiaomei, LIANG Ting, ZHANG Chao, SONG Jing, HOU Guihua. Impact of autophagy on targeting imaging of allorejection with 125I-anti-TLR5 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 46-52.
[3] REN Baoxin, MA Yunfeng, LIU Dianwei, LI Zhuo, JIANG Yong. Effects of Wnt3a on neuronal autophagy and apoptosis in early brain injury after subarachnoid hemorrhage in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(10): 11-15.
[4] HUANG Zhilong, LIU Shuai, WANG Jianwei, HAN Liping, WANG Xiaoqing, LI Xin, BI Dongbin, XIE Fang, NIU Zhihong. Role and possible mechanism of autophagy in ubenimex-induced cell death of renal cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 58-64.
[5] YANG Lu, LIU Yanguo, LI Jisheng, WANG Xiuwen. Effect of bufalin on chemosensitivity to cisplatin in non-small cell lung cancer and the underlying mechanisms [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 6-11.
[6] ZHAO Yongqiang, XIE Xiaoye, CHEN Xuemei, FENG Huiwei, JIA Tao, ZHANG Hui, FAN Xianliang. COX-2 specific inhibitor induced apoptosis and autophagy in Hep-2 cells in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 39-43.
[7] LIU Yimin, DU Lutao, WANG Lili, JIANG Xiumei, LI Juan, QU Ailin, WANG Haiyan, ZHENG Guixi, ZHANG Xin,YANG Yongmei, WANG Chuanxin. Identification and validation of suitable reference genes for the investigation of serum microRNA in bladder cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 86-91.
[8] HAO Fengcheng1,2, SU Zhonghua1,3. Protective effect of autophagy on the inflammation induced by ox-LDL [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 30-34.
[9] SUN Jie, MU Xiaoyan, DONG Xueli. Combinational and sequential effect of sunitinib and gemcitabine on K-RAS mutant A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 45-49.
[10] ZHANG Miaoci, LI Ping, HA Minwin. Clinical observation of recombinant human endostatin combined with gemcitabine in the treatment of platinum-resistant recurrent ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(11): 55-59.
[11] DING Huan1, SUN Ying1, LI Xiao-qing2, LI Li1. Effect of PARP inhibitor combined with Gemcitabine or Docetaxel on the  proliferation of androgen-independent prostate cancer cell line PC3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(1): 33-36.
[12] ZHU Xu-guo, LIU Lei, JIANG Du-yin, YU Guan-ying, LI Chuan, LI Yao-nan, LIU Zhen-zhong, ZHANG Ji-xun. Expression of autophagy-related gene Beclin1 on second-degree scald skin in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 60-63.
[13] ZHENG Yi, JIANG Wei, JIN Xun-bo, WANG Mu-wen, ZHANG Yi-nan, XIA Qing-hua. Valproic acid induces autophagy and regulates the expression of  SPARCL1 protein in prostate cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 32-35.
[14] ZHU Fang-hua1, LIU Yong-qing2, LOU Hong-xiang1. Bisbibenzyl-induced autophagy delays cell death in PC-3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 11-17.
[15] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd